HARTFORD, Conn. (WTNH) — Obesity affects millions of Americans and is now recognized as a chronic disease that requires ...

Doustdar said Medicare coverage and the launch of Novo's new obesity pill should help gradually boost prescription volumes ...

New approaches to obesity treatment are emerging as scientists target underexplored metabolic pathways with the help of artificial intelligence. Demand for better obesity medicines is rising quickly, ...

Researchers are applying insights into the genetic variations and physiology of obesity to apply tailored interventions to ...

The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs without sacrificing efficacy.

Corbus Pharmaceuticals maintains a 'Hold' rating as it advances CRB-701 for HNSCC and CRB-913 for obesity. Click here to read ...